This quarter has seen the health ministry's commitment to developing the biotechnology sector demonstrated by its decision to fast-track stem cell therapy candidate NurOwn, discovered by local company Brainstorm Cell Therapeutics, through early stage clinical trials.
http://www.wirenews.co/mideast/pharmaceuticals/808/new-market-research-report-israel-pharmaceuticals-healthcare-report-q3-2013
http://www.wirenews.co/mideast/pharmaceuticals/808/new-market-research-report-israel-pharmaceuticals-healthcare-report-q3-2013
No comments:
Post a Comment